Identification and Expression of GFAP, YKL-40 and RBP4 in Serum as Noninvasive Biomarkers with Diagnostic and Prognostic Value for Detecting and Monitoring Glioma Patients | Zendy

AI Assistant Blog Pricing

Identification and Expression of GFAP, YKL-40 and RBP4 in Serum as Noninvasive Biomarkers with Diagnostic and Prognostic Value for Detecting and Monitoring Glioma Patients

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.